p.79 抽出テキスト

43. van Dijk WB, Schuit E, van der Graaf R, Groenwold RHH, Laurijssen S, Casadei B, et al. Applicability of European Society of Cardiology guidelines according to gross national income. Eur Heart J 2022;44:598–607. https://doi.org/10.1093/eurheartj/ehac606 44. Sengupta PP, Kluin J, Lee SP, Oh JK, Smits A. The future of valvular heart disease assessment and therapy. Lancet 2024;403:1590–602. https://doi.org/10.1016/s0140- 6736(23)02754-x 45. Lancellotti P, Pibarot P, Chambers J, La Canna G, Pepi M, Dulgheru R, et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 2022;23:e171–232. https://doi.org/10.1093/ehjci/jeab253 46. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017;30: 303–71. https://doi.org/10.1016/j.echo.2017.01.007 47. Popescu BA, Andrade MJ, Badano LP, Fox KF, Flachskampf FA, Lancellotti P, et al. European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography. Eur J Echocardiogr 2009;10: 893–905. https://doi.org/10.1093/ejechocard/jep151 48. Chambers JB, Garbi M, Nieman K, Myerson S, Pierard LA, Habib G, et al. Appropriateness criteria for the use of cardiovascular imaging in heart valve disease in adults: a European Association of Cardiovascular Imaging report of literature review and current practice. Eur Heart J Cardiovasc Imaging 2017;18:489–98. https://doi.org/ 10.1093/ehjci/jew309 49. Agricola E, Ancona F, Bartel T, Brochet E, Dweck M, Faletra F, et al. Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions. Eur Heart J Cardiovasc Imaging 2023;24:e209–68. https://doi.org/10.1093/ehjci/jead096 50. Zoghbi WA, Jone PN, Chamsi-Pasha MA, Chen T, Collins KA, Desai MY, et al. Guidelines for the evaluation of prosthetic valve function with cardiovascular imaging: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2024;37:2–63. https://doi.org/10.1016/j.echo.2023.10.004 51. Faletra FF, Agricola E, Flachskampf FA, Hahn R, Pepi M, Ajmone Marsan N, et al. Three-dimensional transoesophageal echocardiography: how to use and when to use—a clinical consensus statement from the European Association of Cardiovascular Imaging of the European Society of Cardiology. Eur Heart J Cardiovasc Imaging 2023;24:e119–97. https://doi.org/10.1093/ehjci/jead090 52. Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol 2009;54: 2251–60. https://doi.org/10.1016/j.jacc.2009.07.046 53. Genereux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 2017;38: 3351–8. https://doi.org/10.1093/eurheartj/ehx381 54. Stolz L, Doldi PM, Orban M, Karam N, Puscas T, Wild MG, et al. Staging heart failure patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc Interv 2023;16:140–51. https://doi.org/10.1016/j.jcin.2022.10. 032 55. Dietz MF, Prihadi EA, van der Bijl P, Ajmone Marsan N, Delgado V, Bax JJ. Prognostic implications of staging right heart failure in patients with significant secondary tricuspid regurgitation. JACC Heart Fail 2020;8:627–36. https://doi.org/10.1016/j.jchf.2020.02. 008 56. Généreux P, Pibarot P, Redfors B, Bax JJ, Zhao Y, Makkar RR, et al. Evolution and prognostic impact of cardiac damage after aortic valve replacement. J Am Coll Cardiol 2022; 80:783–800. https://doi.org/10.1016/j.jacc.2022.05.006 57. Genereux P, Cohen DJ, Pibarot P, Redfors B, Bax JJ, Zhao Y, et al. Cardiac damage and quality of life after aortic valve replacement in the PARTNER trials. J Am Coll Cardiol 2023;81:743–52. https://doi.org/10.1016/j.jacc.2022.11.059 58. Kwak S, Everett RJ, Treibel TA, Yang S, Hwang D, Ko T, et al. Markers of myocardial damage predict mortality in patients with aortic stenosis. J Am Coll Cardiol 2021;78: 545–58. https://doi.org/10.1016/j.jacc.2021.05.047 59. Magne J, Cosyns B, Popescu BA, Carstensen HG, Dahl J, Desai MY, et al. Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis: an individual participant data meta-analysis. JACC Cardiovasc Imaging 2019;12:84–92. https://doi.org/10.1016/j.jcmg.2018.11.005 60. Prihadi EA, van der Bijl P, Dietz M, Abou R, Vollema EM, Marsan NA, et al. Prognostic implications of right ventricular free wall longitudinal strain in patients with significant functional tricuspid regurgitation. Circ Cardiovasc Imaging 2019;12:e008666. https://doi. org/10.1161/CIRCIMAGING.118.008666 61. Little SH, Rigolin VH, Garcia-Sayan E, Hahn RT, Hung J, Mackensen GB, et al. Recommendations for special competency in echocardiographic guidance of structural heart disease interventions: from the American Society of Echocardiography. J Am Soc Echocardiogr 2023;36:350–65. https://doi.org/10.1016/j.echo.2023.01.014 62. Hahn RT, Saric M, Faletra FF, Garg R, Gillam LD, Horton K, et al. Recommended standards for the performance of transesophageal echocardiographic screening for structural heart intervention: from the American Society of Echocardiography. J Am Soc Echocardiogr 2022;35:1–76. https://doi.org/10.1016/j.echo.2021.07.006 63. Nicoara A, Skubas N, Ad N, Finley A, Hahn RT, Mahmood F, et al. Guidelines for the use of transesophageal echocardiography to assist with surgical decision-making in the operating room: a surgery-based approach: from the American Society of Echocardiography in collaboration with the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons. J Am Soc Echocardiogr 2020; 33:692–734. https://doi.org/10.1016/j.echo.2020.03.002 64. Popescu BA, Stefanidis A, Fox KF, Cosyns B, Delgado V, Di Salvo GD, et al. Training, competence, and quality improvement in echocardiography: the European Association of Cardiovascular Imaging Recommendations: update 2020. Eur Heart J Cardiovasc Imaging 2020;21:1305–19. https://doi.org/10.1093/ehjci/jeaa266 65. Iung B, Delgado V, Lazure P, Murray S, Sirnes PA, Rosenhek R, et al. Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study. Eur Heart J 2018;39:1295–303. https://doi.org/10. 1093/eurheartj/ehx763 66. Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734–44; discussion 744–735. https:// doi.org/10.1093/ejcts/ezs043 67. Ad N, Holmes SD, Patel J, Pritchard G, Shuman DJ, Halpin L. Comparison of EuroSCORE II, original EuroSCORE, and the Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients. Ann Thorac Surg 2016;102:573–9. https://doi.org/ 10.1016/j.athoracsur.2016.01.105 68. O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg 2009;88:S23–42. https://doi.org/10.1016/j.athoracsur.2009.05.056 69. Duchnowski P, Hryniewiecki T, Kuśmierczyk M, Szymanski P. Performance of the EuroSCORE II and the Society of Thoracic Surgeons score in patients undergoing aortic valve replacement for aortic stenosis. J Thorac Dis 2019;11:2076–81. https://doi.org/ 10.21037/jtd.2019.04.48 70. Provenchere S, Chevalier A, Ghodbane W, Bouleti C, Montravers P, Longrois D, et al. Is the EuroSCORE II reliable to estimate operative mortality among octogenarians? PLoS One 2017;12:e0187056. https://doi.org/10.1371/journal.pone.0187056 71. Taleb Bendiab T, Brusset A, Estagnasié P, Squara P, Nguyen LS. Performance of EuroSCORE II and Society of Thoracic Surgeons risk scores in elderly patients undergoing aortic valve replacement surgery. Arch Cardiovasc Dis 2021;114:474–81. https:// doi.org/10.1016/j.acvd.2020.12.004 72. Roques F, Michel P, Goldstone AR, Nashef SAM. The logistic EuroSCORE. Eur Heart J 2003;24:882–3. https://doi.org/10.1016/S0195-668X(02)00799-6 73. Al-Azizi K, Shih E, DiMaio JM, Squiers JJ, Moubarak G, Kluis A, et al. Assessment of TVT and STS risk score performances in patients undergoing transcatheter aortic valve replacement. JSCAI 2023;2:100600. https://doi.org/10.1016/j.jscai.2023.100600 74. Compagnone M, Moretti C, Marcelli C, Taglieri N, Ghetti G, Corsini A, et al. Surgical risk scores applied to transcatheter aortic valve implantation: friends or foes? Short-term and long-term outcomes from a single-center registry. J Invasive Cardiol 2019;31:E282–88. 75. Tarantini G, Lefèvre T, Terkelsen CJ, Frerker C, Ohlmann P, Mojoli M, et al. One-year outcomes of a European transcatheter aortic valve implantation cohort according to surgical risk. Circ Cardiovasc Interv 2019;12:e006724. https://doi.org/10.1161/ CIRCINTERVENTIONS.118.006724 76. Arnold SV, Reynolds MR, Lei Y, Magnuson EA, Kirtane AJ, Kodali SK, et al. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation 2014;129: 2682–90. https://doi.org/10.1161/circulationaha.113.007477 77. Edwards FH, Cohen DJ, O’Brien SM, Peterson ED, Mack MJ, Shahian DM, et al. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol 2016;1:46–52. https://doi.org/10. 1001/jamacardio.2015.0326 78. Iung B, Laouénan C, Himbert D, Eltchaninoff H, Chevreul K, Donzeau-Gouge P, et al. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart 2014;100:1016–23. https://doi.org/ 10.1136/heartjnl-2013-305314 79. Arnold SV, Afilalo J, Spertus JA, Tang Y, Baron SJ, Jones PG, et al. Prediction of poor outcome after transcatheter aortic valve replacement. J Am Coll Cardiol 2016;68: 1868–77. https://doi.org/10.1016/j.jacc.2016.07.762 80. Raposeiras-Roubin S, Adamo M, Freixa X, Arzamendi D, Benito-González T, Montefusco A, et al. A score to assess mortality after percutaneous mitral valve repair. J Am Coll Cardiol 2022;79:562–73. https://doi.org/10.1016/j.jacc.2021.11.041 81. Shah N, Madhavan MV, Gray WA, Brener SJ, Ahmad Y, Lindenfeld J, et al. Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score. JACC Cardiovasc Interv 2022;15:1893–905. https://doi.org/10.1016/j.jcin.2022.08.005 82. Hausleiter J, Lachmann M, Stolz L, Bedogni F, Rubbio AP, Estévez-Loureiro R, et al. Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation

ESC Guidelines                                                                                                                                                                                          4713

Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026